2012

6  Cruz FP, C. Martin, K. Buchholz K, M.J. Lafuente-Monasterio, T. Rodrigues, B. Sönnichsen, R. Moreira, F.J. Gamo, M. Marti, M.M. Mota, M. Hannus, M. Prudêncio. Drug Screen Targeted at Plasmodium Liver Stages Identifies a Potent Multi-Stage Anti-Malarial Drug J Inf Dis., 205, 1278-1286

2011

5 Hellmann JK, Münter S, Kudryashev M, Schulz S, Heiss K, Müller AK, Matuschewski K, Spatz JP, Schwarz US, Frischknecht F. Environmental constraints guide migration of malaria parasites during transmission. PLoS Pathogens 2011 Jun; 7:e1002080

4 Perschmann N, Hellmann JK, Frischknecht F, Spatz JP. Induction of malaria parasite migration by synthetically tunable microenvironments. Nano Lett. 2011 Oct;11:4468-7444.

2010

3 Hellmann JK, Münter S, Wink M, Frischknecht F. Differential effects of the green tea compound EGCG and digitonin on Plasmodium sporozoite motility and viability. PlosONE. 2010, 5, e8682.

2 Hegge S, Kudryashev M, Barniol L, Frischknecht F. Key factors regulating Plasmodium berghei sporozoite survival and transformation revealed by an automated visual assay. FASEB J. 2010 Dec; 24: 5003-5012

2008    

1  Prudencio M, Rodrigues CD, Hannus M, Martin C, Real E, Gonçalves LA, Carret C, Dorkin R, Röhl I, Jahn-Hoffmann K, Luty AJ, Sauerwein R, Echeverri CJ, Mota MM. Kinome-wide RNAi screen implicates at least 5 host hepatocyte kinases in Plasmodium sporozoite infection. 2008. PLoS Pathog 4(11): e1000201.